The U.S. Food and Drug Administration (FDA) recently issued draft guidance on how it will continue to conduct remote regulatory assessments (RRAs) after the COVID-19 public health.
In March 2020, in response to the COVID-19 pandemic and associated health risks and travel restrictions, the Food and Drug Administration (FDA or the Agency) adjusted its field operations.
This week, the U.S. Food and Drug Administration (FDA) issued final guidance concerning regulatory oversight of food imported from Systems Recognition Arrangement (SRA) countries. FDA.